We are using cookies to give you the best experience on our site. Cookies are files stored in your browser and are used by most websites to help personalise your web experience. By continuing to use our website without changing the settings, you are agreeing to our use of cookies.

  • Facebook
  • Twitter
  • Linked In
  • Google+
back top

Senior Director, Medical Affairs Kennedy Sarah

Kennedy Sarah

Biosplice Therapeutics
San Diego, United States of America

Sarah Kennedy, PhD, is the Executive Director, Medical Affairs, at Biosplice Therapeutics. Biosplice is currently developing a novel small molecule, lorecivivint, as a potential treatment for knee osteoarthritis. Sarah’s interests include clinical trial design, mechanisms of pain in osteoarthritis, and factors affecting osteoarthritis disease progression.